DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis

Cancer Letters

Volumn 149, Issue 1-2, 2000, Pages 125-134

  Fujimoto, Junya ^a   Yasui, Wataru ^a   Tahara, Hidetoshi ^a   Tahara, Eiji ^a   Kudo, Yasusei ^b   Yokozaki, Hiroshi ^a   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Immunohistochemistry; Intestinal metaplasia; Promoter methylation; pS2

Indexed keywords

CELL DNA; MESSENGER RNA; PROTEIN PS2;

ADENOCARCINOMA; ADENOMA; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE METAPLASIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR DIFFERENTIATION;

CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; GENETIC MARKERS; HUMANS; PRECANCEROUS CONDITIONS; PROMOTER REGIONS (GENETICS); PROTEINS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0033952575     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00349-3     Document Type: Article

References (38)

1. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10:1982;7895-7903.
2. Jakowlew S.B., Breathnach R., Jeltsch J.M., Masiakowski P., Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res. 10:1984;2861-2878.
3. Thim L. A new family of growth factor-like peptides: 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett. 250:1989;85-90.
4. Rio M.C., Bellocq J.P., Daniel J.Y., Tomasetto C., Lathe R., Chenard M.P., Batzenschlager A., Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science. 241:1988;705-708.
5. Theisinger B., Welter C., Seitz G., Rio M.C., Lathe R., Chambon P., Blin N. Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur. J. Cancer. 27:1991;770-773.
6. Wright N.A., Poulsom R., Stamp G.W., Hall P.A., Jeffery R.E., Longcroft J.M., Rio M.C., Tomasetto C., Chambon P. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol. 162:1990;279-284.
7. Wright N.A., Poulsom R., Stamp G., Van N.S., Sarraf C., Elia G., Ahnen D., Jeffery R., Longcroft J., Pike C. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 104:1993;12-20.
8. Welter C., Theisinger B., Seitz G., Tomasetto C., Rio M.C., Chambon P., Blin N. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab. Invest. 66:1992;187-192.
9. Welter C., Theisinger B., Rio M.C., Seitz G., Schuder G., Blin N. Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumors. Int. J. Cancer. 56:1994;52-55.
10. Müller W., Borchard W. pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival. J. Pathol. 171:1993;263-269.
11. Higashiyama M., Doi O., Kodama K., Yokouchi H., Inaji H., Nakamori S., Tateishi R. Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma. Eur. J. Cancer. 30:1994;792-797.
12. Bonkhoff H., Stein U., Welter C., Remberger K. Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum. Pathol. 26:1995;824-828.
13. Rio M.C., Chenard M.P., Wolf C., Marcellin L., Tomasetto C., Lathe R., Bellocq J.P., Chambon P. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology. 100:1991;375-379.
14. Hoosein N.M., Thim L., Jorgensen K.H., Brattain M.G. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett. 247:1989;303-306.
15. Playford R.J., Marchbank T., Goodlad R.A., Chinery R.A., Poulsom R., Hanby A.M. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA. 93:1996;2137-2142.
16. Lefebvre O., Chenard M.P., Masson R., Linares J., Dierich A., LeMeur M., Wendling C., Tomasetto C., Chambon P., Rio M.C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 274:1996;259-262.
17. Wu M.S., Shun C.T., Wang H.P., Lee W.J., Wang T.H., Lin J.T. Loss of pS2 protein expression is an early event of intestinal-type gastric cancer. Jpn. J. Cancer Res. 89:1998;278-282.
18. Martin V., Ribieras S., Song W.X., Rio M.C., Dante R. Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 gene and its expression in human breast cancer cell lines. Gene. 157:1995;261-264.
19. Gastric Cancer, J.R.S.F. Japanese Classification of Gastric Carcinoma. 1995;Kanehara, Tokyo. 1st English edition.
20. Ochiai A., Yasui W., Tahara E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res. 76:1985;1064-1071.
21. Sekiguchi M., Sakakibara K., Fujii G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn. J. Exp. Med. 48:1978;61-68.
22. Yanagihara K., Seyama T., Tsumuraya M., Kamada N., Yokoro K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res. 51:1991;381-386.
23. Motoyama T., Hojo H., Watanabe H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol. Jpn. 36:1986;65-83.
24. Kitadai Y., Yasui W., Yokozaki H., Kuniyasu H., Ayhan A., Haruma K., Kajiyama G., Johnson G.R., Tahara E. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas. Jpn. J. Cancer Res. 84:1993;879-884.
25. Nakayama J., Tahara, H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18:1998;65-68.
26. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:1997;808-811.
27. Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugimura T., Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA. 92:1995;7416-7419.
28. Yasui W., Tahara H., Tahara E., Fujimoto J., Nakayama J., Ishikawa F., Ide T., Tahara E. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn. J. Cancer Res. 89:1998;1099-1103.
29. Naka K., Yokozaki H., Domen T., Hayashi K., Kuniyasu H., Yasui, W., Lotan R., Tahara E. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein. Differentiation. 61:1997;313-320.
30. Correa P. The new era of cancer epidemiology. Cancer Epidemiol. Biomarkers Prev. 1:1991;5-11.
31. Tahara E., Kuniyasu H., Yasui W., Yokozaki H. Gene alterations in intestinal metaplasia and gastric cancer. Eur. J. Gastroenterol. Hepatol. 1994;S97-102.
32. Yokozaki H., Shitara H., Fujimoto J., Hiyama T., Yasui W., Tahara E. Alteration p73 gene preferentially in foveolar type gastric carcinomas. Int. J. Cancer. 83:1999;192-196.
33. Brown A.M., Jeltsch J.M., Roberts M., Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. USA. 81:1984;6344-6348.
34. Berry M., Nunez A.M., Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA. 86:1989;1218-1222.
35. Koshiyama M., Yoshida M., Konishi M., Takemura M., Yura Y., Matsushita K., Hayashi M., Tauchi K. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status. Int. J. Cancer. 74:1997;237-244.
36. Singh S., Poulsom R., Hanby A.M., Rogers L.A., Wright N.A., Sheppard M.C., Langman M.J. Expression of oestrogen receptor and oestrogen-inducible genes pS2 and ERD5 in large bowel mucosa and cancer. J. Pathol. 184:1998;153-160.
37. Yokozaki H., Takekura N., Takanashi A., Tabuchi J., Haruta R., Tahara E. Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis. Virchows Arch. A Pathol. Anat. Histopathol. 413:1988;297-302.
38. Kanai Y., Ushijima S., Ochiai A., Eguchi K., Hui A., Hirohashi S. hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett. 122:1998;135-141.